Key Insights

Highlights

Success Rate

80% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

8.7%

2 terminated out of 23 trials

Success Rate

80.0%

-6.5% vs benchmark

Late-Stage Pipeline

9%

2 trials in Phase 3/4

Results Transparency

0%

0 of 8 completed with results

Key Signals

80% success

Data Visualizations

Phase Distribution

20Total
Not Applicable (15)
P 1 (3)
P 3 (1)
P 4 (1)

Trial Status

Completed8
Unknown7
Not Yet Recruiting3
Terminated2
Active Not Recruiting2
Suspended1

Trial Success Rate

80.0%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (23)

Showing 20 of 20 trials
NCT03339037Not ApplicableTerminatedPrimary

Hyperbaric Oxygen Therapy Effect on Post Concussion Syndrome in Children

NCT03144206Phase 4Active Not Recruiting

Hyperbaric Oxygen Therapy for Soft Tissue Sarcoma Pilot Study

NCT06619717Not ApplicableTerminatedPrimary

Optimal Number of Hyperbaric Oxygen Treatments for Carbon Monoxide Poisoning

NCT03980210Not ApplicableCompletedPrimary

Effect of Hyperbaric Oxygen Therapy on Microcirculation

NCT06665633Phase 1Completed

Treatment of U.S. Veterans With Mild Traumatic Brain Injury With Hyperbaric Oxygen Therapy

NCT07140198Not ApplicableNot Yet Recruiting

Hyperbaric Oxygen Therapy to Improve Autologous Fat Graft Intake in Irradiated Breast

NCT07120581Active Not Recruiting

Hyperbaric Oxygen Therapy Used on Severely Injured Healthy Individuals With Fungal Infections

NCT06819202Not Yet Recruiting

Effect of Hyperbaric Oxygen Therapy(HBOT) on Patients With Sudden Sensorineural Hearing Loss(SSNHL) and Coagulation Function

NCT06954389Not ApplicableCompletedPrimary

Hyperbaric Oxygen Therapy as a Neuroprotective Modality in Pediatric Acquired Brain Injury With Motor Disability

NCT06954376Not ApplicableCompletedPrimary

Hyperbaric Oxygen Therapy as a Neuroprotective Intervention in Pediatric Acquired Brain Injury With Cognitive Disability

NCT05980195Not ApplicableNot Yet Recruiting

Cognitive Improvement After Carotid Stenting in Hyperbaric Oxygen Therapy Trial

NCT05031949Phase 1Unknown

Hyperbaric Oxygen Therapy Combined Camrelizumab in Patients With Advanced/Metastatic Hepatocellular Carcinoma

NCT05289700Phase 3Unknown

Hyperbaric-oxygen Therapy (HBOT) Versus Placebo for Treating Vaso-Occlusive Crisis (VOC) in Sickle Cell Disease (SCD)

NCT04311437Not ApplicableUnknownPrimary

Effect of Self-acupressure on Middle Ear Barotrauma Associated With Hyperbaric Oxygen Therapy

NCT05136716Not ApplicableCompleted

Effect of Hyperbaric Oxygen Therapy on Cerebral Palsy

NCT05078073Not ApplicableUnknownPrimary

HBOT in the Treatment and Prevention of aGVHD

NCT04376359Not ApplicableUnknownPrimary

The Effectiveness of Hyperbaric Oxygen Therapy on Pneumonia Complicating Stroke

NCT03615755Not ApplicableCompletedPrimary

Short Duration Hyperbaric Oxygen Therapy to Improve HbA1c, Leukocyte, and Serum Creatinine

NCT04358796Not ApplicableCompletedPrimary

Measuring Cognitive Enhancement During Hyperbaric Oxygen Treatments

NCT03526796Not ApplicableUnknown

Hyperbaric Oxygen Therapy for Antibiotic Refractory Pouchitis

Scroll to load more

Research Network

Activity Timeline